Schedule 13G ownership disclosure
Sigyn Therapeutics, Inc.
Security class unavailable · CUSIP: 82674U106
Event date: 2020-10-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-033914
- Form type
- SC 13G
- Filer
- Osher Capital Partners LLC
- CIK
- CIK 1586280
- Filed
- Oct 29, 2020
- Reporting period
- Oct 19, 2020
- Description
- Schedule 13G beneficial ownership